AlphaFold predicted structure
AIMP2 · Q13155

Mean pLDDT
81.1/ 100
Confident
320 residues
Confidence breakdown
- Very high(≥ 90)58%
- Confident(70–90)15%
- Low(50–70)13%
- Very low(< 50)13%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
aminoacyl tRNA synthetase complex interacting multifunctional protein 2
Annotations refreshed 9 hours ago.
Moderate Evidence (Amber)
Early onset or syndromic epilepsy
BIALLELIC, autosomal or pseudoautosomalFetal anomalies
BIALLELIC, autosomal or pseudoautosomalIntellectual disability
BIALLELIC, autosomal or pseudoautosomalleukodystrophy, hypomyelinating, 17
hereditary disease
Neurodevelopmental abnormality
Parkinson disease
cancer
lung carcinoma
lung cancer
neoplasm
nasopharyngeal carcinoma
acute myeloid leukemia
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Aminoacyl tRNA synthase complex-interacting multifunctional protein 2
Required for assembly and stability of the aminoacyl-tRNA synthase complex (PubMed:19131329). Mediates ubiquitination and degradation of FUBP1, a transcriptional activator of MYC, leading to MYC down-regulation which is required for aveolar type II cell differentiation. Blocks MDM2-mediated ubiquitination and degradation of p53/TP53. Functions as a proapoptotic factor
AIMP2 · Q13155

Mean pLDDT
81.1/ 100
Confident
320 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0